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Abstract
Ubiquitin-specific protease 19 (USP19) is one of the deubiquitinating enzymes (DUBs)
involved in regulating the ubiquitination status of substrate proteins. There are two major
isoforms of USP19 with distinct C-termini; the USP19_a isoform has a transmembrane
domain for anchoring to the endoplasmic reticulum, while USP19_b contains an EEVD
motif. Here, we report that the cytoplasmic isoform USP19_b up-regulates the protein levels
of the polyglutamine (polyQ)-containing proteins, ataxin-3 (Atx3) and huntingtin (Htt), and
thus promotes aggregation of their polyQ-expanded species in cell models. Our data dem-
onstrate that USP19_b may orchestrate the stability, aggregation and degradation of the
polyQ-expanded proteins through the heat shock protein 90 (HSP90) chaperone system.
USP19_b directly interacts with HSP90 through its N-terminal CS (CHORD and SGT1)/P23
domains. In conjunction with HSP90, the cytoplasmic USP19 may play a key role in triage
decision for the disease-related polyQ-expanded substrates, suggesting a function of
USP19 in quality control of misfolded proteins by regulating their protein levels.
Introduction
Protein homeostasis or proteostasis is vital to normal cellular growth and function, which can
be perturbed by many factors, such as physiological stress or genetic mutation [1, 2]. Cells have
evolved two kinds of elaborated systems, molecular chaperones and protein degradation
machineries, for quality control of cellular proteins [3]. Molecular chaperones can recognize
unfolded, misfolded or damaged proteins and facilitate their refolding to native conformations
[4]. Irreversibly misfolded proteins may form aggregates and/or undergo degradation mainly
through ubiquitin-proteasomal pathway [4]. In eukaryotic cells, whether a misfolded protein
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forms aggregates or has to be degraded is elaborately regulated by cross-talk between these two
mechanisms, in which numerous adaptor proteins [5, 6], chaperones [7, 8] and/or co-chaper-
ones [9] are closely associated. In particular, ubiquitination of substrates is counteracted by
deubiquitination allowing escape of misfolded and aggregated proteins from degradation [10,
11]. On the other hand, the accumulation of insoluble aggregates may result in cell toxicity and
ultimately the pathogenesis of several neurodegenerative diseases. Among these, polyglutamine
(polyQ)-expanded ataxin-3 (Atx3) and huntingtin (Htt) are the main causative proteins of spi-
nocerebellar ataxia type-3 (SCA3) and Huntington’s disease, respectively [12, 13].
Ubiquitin-specific protease 19 (USP19) is a member of the deubiquitinating enzyme (DUB)
family, whose structure and function are largely unknown [14]. There are two major isoforms
of USP19 that differ in their C-termini; one contains a transmembrane domain (TMD) for
anchoring the protein to the endoplasmic reticulum (ER) and is involved in ER-associated deg-
radation (ERAD) of substrates [15], the other has a C-terminal EEVD extension, putatively
interacting with tetratricopeptide repeat (TPR)-containing proteins [16], such as carboxyl-ter-
minus of Hsc70 interacting protein (CHIP) [17]. Interestingly, both forms of USP19 contain
two CS (CHORD-SGT1)/P23 domains in their N-termini that potentially interact with the
HSP90 chaperone [18], and a central USP domain that has the deubiquitinating activity [15].
Recently, both isoforms of USP19 have been verified in muscle cells by qPCR using isoform-
specific primers [19]. Up to date, studies have focused on the ER-resident isoform of USP19
(USP19_a), which participates in the unfolded protein response and rescues the ERAD sub-
strates [15, 20]. Besides, USP19 has also been proposed to play a role in regulating the stabilities
of the ubiquitin ligase KPC1 [21], inhibitors of apoptosis c-IAP1 and c-IAP2 [22], and hypoxia
inducible factor 1α (HIF-1α) during hypoxia [23].
As a multi-domain DUB, USP19 is implicated in regulating protein deubiquitination and
triage decision, which might be closely associated with protein aggregation and degradation
[24]. In this work, we studied the potential regulatory functions of USP19 on polyQ-containing
proteins, Atx3 [9] and Htt [25]. We found that the cytoplasmic isoform USP19_b up-regulates
the protein levels of these proteins and aggravates aggregation and cytotoxicity of the polyQ-
expanded species depending on the HSP90 chaperone. Our findings support a role of USP19 in
regulating the balance between aggregation and degradation of cellular polyQ-expanded pro-
teins in the quality control [24].
Materials and Methods
Materials and expression plasmids
17-AAG (17-(Allylamino)-17- demethoxygeldanamycin) and MG132 were purchased from
Sigma and Calbiochem, respectively. The antibodies against HA, FLAG and endogenous CHIP
were obtained from Sigma, while those against HSP90 and Myc were from Cell Signaling and
those against GFP, ubiquitin and actin from Santa Cruz. The anti-USP19 antibody (A301-
587A) was purchased from Bethyl Laboratories. The goat anti-mouse IgG-HRP antibody, goat
anti-rabbit IgG-HRP, rabbit anti-goat IgG-HRP secondary antibodies and FITC-conjugated
anti-mouse antibody, and Cyanine 3 conjugated anti-rabbit secondary antibody were pur-
chased from Jackson Immuno-Research. The proteins were visualized using an ECL detection
kit (Amersham Pharmacia Biotech). CytoTox-ONE™ reagent was a product of Promega.
Human USP19_a, USP19_b, USP5 and all the mutants were cloned into HA-pcDNA3 vector.
The mutants (C506S, CS1M, CS2M, CS12M, ΔN393) of USP19_b, C335A mutant of USP5 and
the Atx3100Q-UIM
mut (S236A/S256A) mutant were generated using site-directed mutagenesis
via PCR technique. The expression plasmid for human HSP90 was cloned into pcDNA3.1-
Myc/His, and the pEGFP-N1 vector was used to express EGFP. The polyQ proteins (including
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Atx322Q, Atx3100Q, Atx3100Q-UIM
mut, Htt-N55218Q, Htt-N552100Q and Htt-N171100Q) and
TDP-35 were cloned into pcDNA3-FLAG plasmid.
Cell culture and transfection
Human HEK 293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Invi-
trogen) supplemented with 10% fetal bovine serum (Gibco) and grown at 37°C under a humid-
ified atmosphere containing 5% CO2. All the plasmid transfections were performed using
Fugen (Roche) or PolyJetTM (SignaGen Laboratories) reagent following the manufacturer’s
instructions.
Immunofluorescence imaging
Cells were seeded onto poly-L-lysine hydrobromide-coated coverslips and transfected under a
low confluence. After culturing for another 36–48 hrs, cells were harvested for immunofluores-
cence assay. Briefly, the cells were washed with a PBS buffer (10 mM Na2HPO4, 1.8 mM
KH2PO4, 140 mMNaCl, 2.7 mM KCl, pH 7.3) three times and fixed with 4% paraformalde-
hyde for 30 min, rinsed and permeabilized with the PBS plus 0.1% Triton X-100, blocked in 3%
bovine albumin, and then stained with primary antibody for 1 hr at room temperature. After
washing the unbound antibody, FITC or TRITC conjugated secondary antibody was used to
label the protein. The nuclei were stained with Hoechst (Sigma) and the ER was imaged with
an antibody against calnexin. Fluorescence imaging was carried out by using a Leica TCS SP2
confocal microscope (Leica Microsystems).
Co-immunoprecipitation andWestern blotting
After transfection and cultivation for 24–48 hrs, HEK 293T cells were lysed in RIPA buffer (50
mM Tris–HCl, pH 7.5, 150 mMNaCl, 1 mM EDTA, 1 mM PMSF, cocktail protease inhibitor
(Roche), 1% NP-40, 0.05% SDS) and the whole cell lysates were subjected to SDS-PAGE with
12% acrylamide gel and then transferred onto PVDF membranes (PerkinElmer). For co-IP
experiments, the cell lysates were centrifuged at 13,000 g for 10 min, and the supernatants were
mixed with protein A/G beads conjugated with appropriate specific primary antibodies. After
incubating for 2–4 hrs at 4°C, the beads were washed with the lysis buffer for three times to
remove the unbound proteins, and the precipitated proteins were subjected to immunoblotting
analysis. The blots were incubated with appropriate specific antibodies and horseradish peroxi-
dase-conjugated anti-IgG secondary antibody. The proteins were visualized using an ECL
detection kit (Amersham Pharmacia Biotech). The band intensity was quantified by using
Scion Image, and its integral area of gray value was calculated and normalized to that of the
control. Data were statistically analyzed with one-way ANOVA.
Supernatant/pellet fractionation
The cell lines over-expressing Atx3 transfected with USP19_b or its mutants were lysed with
RIPA buffer on ice for 30 min and centrifuged at 16,000 g for 10 min. The pellet was suffi-
ciently washed with RIPA buffer for three times and the cytosolic supernatant were added with
equal amount of 2 x loading buffer (4% SDS) and subjected to Western blotting.
Filter trap experiment
The filter trap experiment was performed as described previously [26] for examining protein
aggregation in cell lysates. Cells were harvested and lysed in RIPA buffer (50 mM Tris–HCl,
pH 7.5, 150 mMNaCl, 1 mM EDTA, 1% NP-40, protease inhibitor cocktail (Roche)). An equal
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volume of SDS buffer (4% SDS, 100 mM DTT) was added to the total lysates and boiled at
100°C for 5 min. The mixture was centrifuged at 12,000 rpm for 5 min and the supernatant
was filtered through a cellulose acetate membrane (0.2 μm pore size, Whatman). The mem-
brane was washed 2 times with 2% SDS and the aggregates retained on the membrane were
detected with anti-FLAG antibody.
GST pull-down experiment
The His-tagged HSP90 (in pET-28a) and GST-fused CS1 (residues 75–209) or CS2 (273–393)
domain of USP19_b (in pGEX-4T-3) were expressed in E. coli BL21 (DE3) strain. The His-
tagged HSP90 was purified through a Ni2+-NTA column (Qiagen), while GST-fused proteins
were purified using the glutathione Sepharose 4B column (Amersham Bioscience). GST or
GST-fused proteins were incubated with the glutathione Sepharose 4B beads in a PBS buffer
(10 mMNa2HPO4, 140 mMNaCl, 2.7 mM KCl, 1.8 mM KH2PO4, pH 7.4), and the suspension
was agitated at 4°C for 30 min. The beads were washed three times in the same buffer to
remove any unbound protein. An equal molar amount of HSP90 was added, and the suspen-
sion was agitated at 4°C for about 2 hrs. After excessive washing, the beads were re-suspended
in the sample buffer and subjected to SDS-PAGE followed by Coomassie staining.
RNA interference
For knockdown of human endogenous USP19, three different siRNA duplexes (#1,
SI00758163; #2, SI00758170; #3, SI00758177) were purchased from Qiagen. The target
sequence of the viral glycoprotein VSVG (ATTGAACAAACGAAAGGA) was used for a con-
trol. Transfection of the siRNAs was performed using Lipofectamine™ (Invitrogen) or INTER-
FERin (Polyplus-transfection) transfection reagent with a dish of 100 pmol/6 cm2 of siRNA
according to the manufacturer’s instruction. The cells were harvested for assays after 72 hrs.
Cell viability assay [27]
HEK 293T cells transfected with equal amount of Atx3100Q or Htt-N171100Q and USP19_b or
its C506S mutant were plated on a 96-well dish and cultured for another 48 hrs in 100-μL
medium. The cytotoxicities of polyQ proteins were measured using the CytoTox-ONETM
(Promega) assay based on LDH release according to the manufacturer’s instruction. The fluo-
rescence was recorded on Berthold LB940 with the excitation wavelength of 540 nm and an
emission wavelength of 590 nm. The relative cytotoxicity was estimated by subtracting the
background value, and the data were statistically analyzed with one-way ANOVA and pre-
sented as Mean ± SD.
Results
Human usp19 gene is located in chromosome 3 (3p21.31) and can be transcribed and trans-
lated into two major isoforms [28]. Isoform USP19_a contains a C-terminal TMD region and
is anchored to endoplasmic reticulum [15]. Sequence alignment illustrates that the C-terminal
region of USP19_b is characterized by an EEVDmotif but without hydrophobic TMD (Fig
1A). Our immunofluorescence microscopic experiment confirmed the previous observation
that USP19_a is an ER-anchored protein co-localizing with calnexin (an ER marker) (S1A Fig).
In contrast, USP19_b did not co-localize with calnexin while showing a cytoplasmic staining
(S1B Fig), as observed for USP19_a upon deletion of the C-terminal TMD [15].
Orchestration of PolyQ-Protein Aggregation by USP19
PLOSONE | DOI:10.1371/journal.pone.0147515 January 25, 2016 4 / 16
USP19_b up-regulates the protein levels of Atx3 and Htt-N552
We applied isoform I of Atx3 and N-terminal Htt (Htt-N552) as polyQ-containing substrates
to study the potential regulatory functions of USP19 (S2 Fig). We co-transfected USP19_b or
its active-site mutant (C506S) with polyQ-expanded Atx3 (Atx3100Q) into HEK 293T cells and
analyzed the amounts of Atx3100Q in cell lysates by Western blotting. The result showed that
USP19_b significantly increased the protein level of Atx3100Q in a manner dependent on the
ubiquitin-specific protease activity (Fig 1B). Moreover, the increase of Atx3100Q led by
Fig 1. USP19_b increases the protein levels of Atx3100Q and Htt-N552100Q. A, Domain architecture and sequence alignment of USP19 isoforms. USP19
contains two CHORD-SGT1 domains (namely CS1 and CS2) at its N-terminus and a large USP domain. Instead of a transmembrane domain in USP19_a,
there is a relatively hydrophilic region and an EEVDmotif in the C-terminus of USP19_b.B andC, Effects of USP19_b on the protein levels of Atx3100Q (B)
and Htt-N552100Q (C). HEK 293T cells were transfected with equal amount of FLAG-tagged Atx3100Q or Htt-N552100Q and vector, HA-USP19_b or its C506S
mutant, and 48 hrs later, the cells were harvested and lysed for Western blotting with the indicated antibodies.D, Effect of USP19_b on the protein level of
endogenous Atx3. E, Effect of USP5 on the protein level of Atx3100Q. FLAG-tagged Atx3100Q was co-transfected with HA-USP5 or its active-site mutant
(C335A) into HEK 293T cells. F andG, Knockdown of USP19 reduces the protein level of Atx3100Q (F) or Htt-N552100Q (G) in HEK 293T cells. Cells were
transfected with FLAG-tagged Atx3100Q or Htt-N552100Q and USP19 siRNA. After 72 hrs, the cells were harvested and the lysates were subjected to Western
blotting with the indicated antibodies. Ctrl, VSVG siRNA; 1#, 3#, two siRNAs against USP19. The band intensities were quantitated by using Scion Image.
Data were normalized to mock transfected with vector or control siRNA, and statistically analyzed with one-way ANOVA and presented as Mean ± SEM
(n = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.001; N.S., no significance.
doi:10.1371/journal.pone.0147515.g001
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USP19_b was dose-dependent (S3A Fig). However, expression of USP19_b did not affect the
levels of HSP90 and CHIP, two chaperones involved in quality control of misfolded proteins
(Fig 1B, lower rows). Similarly, USP19_a could also up-regulate the protein level of Atx3100Q in
a dose-dependent manner (S3A Fig, right panels), suggesting that the C-terminal EEVD
sequence of the b-form and the ER anchor location of the a-form are not essential to this effect.
Similar results were also observed when co-transfection of USP19_b with Htt-N552100Q that
USP19_b up-regulated the protein level of Htt-N552100Q, whereas the C506S mutant had
attenuated the effect (Fig 1C). It is noteworthy that the C506S mutant can partially increase the
protein level of Atx3100Q and Htt-N552100Q, but this effect is relatively small as compared with
that of the wild type. We speculate that the C506S mutation does not abolish the activity of
USP19_b completely, which is consistent with the previous observation that the C506S mutant
of USP19_a has partial activity [15]. We also examined whether USP19_b exerts regulatory
functions on normal polyQ-length proteins. Similar regulatory effect by USP19_b was
observed in overexpressed Atx322Q (S3B Fig) and Htt-N55218Q (S3C Fig). Furthermore,
USP19_b could also up-regulate the protein level of endogenous Atx3 (Fig 1D), albeit this
increasing effect was not obvious as that on the overexpressed Atx322Q (S3B Fig).
To exclude the possibility that other DUB could regulate the levels of these two polyQ pro-
teins, we examined USP5, a well-studied DUB with relatively strong deubiquitination activity
[10, 29]. The data showed that neither USP5 nor its C335A mutant presented such effects on
the protein levels of Atx3100Q (Fig 1E) and Htt-N552100Q (S4A Fig). Moreover, we applied GFP
as a control to eliminate the possible artifacts caused by overexpression, and found that
USP19_b had no effect on the GFP level (S4B Fig). We also examined the possible role of
USP19_b on TDP-35, a C-terminal 35-kDa fragment of TDP-43, which forms cytoplasmic
inclusions or aggregates and is implicated in the pathogenesis of amyotrophic lateral sclerosis
[30]. The data showed that USP19_b did not increase the TDP-35 level (S4C Fig).
We next examined the effect of usp19 silencing on the protein levels of Atx3100Q and Htt-
N552100Q, and observed that knockdown of USP19 significantly reduced the protein levels of
Atx3100Q (Fig 1F) and Htt-N552100Q (Fig 1G) both in HEK 293T cells and in human retinal
pigment epithelial (RPE1) cells (S3D Fig). Collectively, these data illustrate that USP19_b up-
regulates the protein levels of the polyQ-containing proteins.
USP19_b promotes aggregation of polyQ-expanded Atx3 and Htt-N552
To get insights into whether USP19_b affects the soluble or aggregated form of polyQ-
expanded proteins, we firstly analyzed the supernatant and pellet fractions of cell lysates and
found that overexpression of USP19_b increased the amounts of the pellet fraction of Atx3100Q
as well as the supernatant (S5 Fig). It suggests that USP19_b up-regulates the Atx3100Q level,
while increase of the protein amount leads to aggregation. We then detected the aggregates by
using filter trap experiments [26, 31]. The data showed that USP19_b could increase the
amounts of SDS-resistant aggregates both in Atx3100Q (Fig 2A) and Htt-N552100Q (Fig 2B), but
the C506S mutant had little effect on aggregate formation, although the proteins with normal
polyQ lengths (Atx322Q, Htt-N55218Q) did not form SDS-resistant aggregates (Fig 2, left pan-
els). This implies that active USP19_b stimulates aggregation of the polyQ-expanded proteins
in cells through up-regulating their protein levels.
As demonstrated, polyQ-expanded proteins, a culprit of related neurodegeneration, are sus-
ceptible to adopt non-native misfolded conformations that eventually form toxic oligomers
and aggregates [32, 33]. We therefore analyzed the cytotoxicities of Atx3100Q and Htt-
N171100Q in the context of overexpressed USP19_b in HEK 293T cells. As expected, neither
USP19_b nor its C506S mutant alone affected the cytotoxicity, whereas overexpression of
Orchestration of PolyQ-Protein Aggregation by USP19
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Atx3100Q or Htt-N171100Q led to an increase in toxicity (Fig 3). The cytotoxicities caused by the
polyQ-expanded proteins were significantly enhanced by co-expression of wild-type USP19_b
but not the C506S mutant. It indicates that the cytotoxicities of the polyQ-expanded proteins
are associated with the deubiquitinating activity of USP19_b. Thus, USP19_b aggravates the
cytotoxicities of the polyQ-expanded proteins by increasing their protein levels and possibly
aggregate fractions.
USP19_b interacts with HSP90 via its CS domains
Because USP19_b contains two CS domains (Fig 1A) potentially interacting with HSP90 [18],
we attempted to elucidate whether USP19 regulates misfolded proteins through the HSP90
chaperone system [7]. We firstly investigated whether USP19_b interacts with HSP90. In the
co-transfected HEK 293T cells, USP19_b could be immunoprecipitated by HSP90 (Fig 4A). A
similar experiment also showed that overexpressed USP19_b could immunoprecipitate the
endogenous HSP90 as well as CHIP proteins (Fig 4B). However, inconsistent with the recent
Fig 2. USP19_b promotes aggregation of Atx3100Q and Htt-N552100Q as evidenced by filter trap analysis. FLAG-tagged Atx3100Q (A) or Htt-N552100Q
(B) was co-transfected with USP19_b or its C506Smutants into HEK 293T cells. Atx322Q and Htt-N55218Q were set as controls. About 48 hrs after
transfection, the cell lysates were subjected to filter trap andWestern blotting analyses with an anti-FLAG antibody. Data were quantitated with the relative
band intensities and presented as Mean ± SEM (n = 3). **, p < 0.01; ***, p < 0.001; N.S., no significance.
doi:10.1371/journal.pone.0147515.g002
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Fig 3. USP19_b stimulates the cytotoxicities of polyQ-expandedAtx3100Q (A) and Htt-N171100Q (B).Here Htt-N171100Q refers to the N-terminal 171-residue
fragment of Htt with 100Q. HEK 293T cells were co-transfected with the plasmids as indicated. After 48-hour culture, the cells were subjected to CytoTox-ONE™
assay. Data were statistically analyzed with one-way ANOVA and presented as Mean ± SD (n = 6). *, p < 0.05; **, p < 0.01; N.S., no significance.
doi:10.1371/journal.pone.0147515.g003
Fig 4. USP19_b associates with HSP90 through CS domains. A, Co-IP experiment showing interaction of USP19_b with HSP90. HEK 293T cells were co-
transfected with HA-USP19_b and HSP90-Myc plasmids, and then the cell lysates were subjected to immunoprecipitation with protein A/G-conjugated anti-
Myc antibody. The control lane is in the presence of only protein A/G.B, Immunoprecipitation with the endogenous HSP90 and CHIP by USP19_b. HEK 293T
cells were transiently transfected with HA-USP19_b expression plasmid.C, GST pull-down experiment showing direct interaction between CS1 (residues 75–
209) or CS2 (273–393) domain of USP19_b and HSP90. GST protein was set as a control. The arrow indicates the band of HSP90.D, Sequence alignment of
the CS domains from USP19 (Homo Sapiens) and Sgt1a (Arabidopsis). The conserved residues that are putatively important to HSP90 binding were selected
for mutation. E, Co-IP experiment of USP19_b or its CS-domain mutants with HSP90. CS1M, K176A/Q178A in the CS1 domain; CS2M, Y290A/Y302A in the
CS2 domain; CS12M, double-domain mutant. HSP90 was Myc tagged, while USP19_b and its mutants were HA tagged.
doi:10.1371/journal.pone.0147515.g004
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data from immunoprecipitation experiment [20], GST pull-down showed that both CS1 and
CS2 domains of USP19_b directly interacted with HSP90 (Fig 4C).
Based on sequence comparison and the complex structure of Sgt1a CS domain with HSP90
[18] (Fig 4D), we mutated two conserved binding-site residues on the CS1 (CS1M, K176A/
Q178A) and CS2 (CS2M, Y290A/Y302A) domains, respectively. Co-IP experiment demon-
strated that the CS mutants, especially the double-domain mutant (CS12M), significantly
attenuated the interaction between USP19_b and HSP90 to different extents (Fig 4E). These
data strongly indicate that USP19_b directly interacts with HSP90 through its CS domains.
Collectively, the cytoplasmic USP19 associates with HSP90 potentially forming a dynamic
complex in cells, which may function in quality control for the polyQ-expanded proteins.
USP19_b modulates aggregation of the polyQ-expanded proteins
through the HSP90 chaperone system
It was reported previously that, as normal Atx3 [34], the polyQ-expanded proteins are mainly
degraded through the ubiquitin-proteasome pathway [9, 34]. To ask whether HSP90 is
involved in the USP19_b functionality for regulating polyQ-expanded substrates, we applied
an HSP90 inhibitor 17-AAG and detected its effects on the substrates [35]. When the cells
overexpressing a polyQ-expanded protein were treated with 17-AAG, the total amounts of
Atx3100Q (Fig 5A) and Htt-N552100Q (Fig 5B) were decreased considerably. We also detected
the SDS-resistant aggregates by filter trap assay; the aggregates of both Atx3100Q (Fig 5C) and
Htt-N552100Q (Fig 5D) were also decreased with the increase of 17-AAG. It suggests that
HSP90 is involved in stabilizing the polyQ-expanded proteins or functions in accumulation of
the misfolded aggregates.
To verify this finding that USP19_b up-regulates the protein levels of polyQ proteins and
thus promotes aggregation of their polyQ-expanded species through HSP90, we determined
the effects of the USP19_b mutants on the total amounts and the aggregates of Atx3100Q and
Htt-N552100Q in cell lysates. The data clearly indicated that the CS-domain mutation in
USP19_b significantly abolished its effect to increase the total amounts (Fig 6A and 6B) and
the aggregates (Fig 6C and 6D) of these two substrates. Again, USP19_b could up-regulate the
protein levels of overexpressed Atx3 and Htt-N552 with normal polyQ lengths, whereas the
CS-domain mutant significantly reduced this effect (S6 Fig). Collectively, the soluble and
aggregated forms of the polyQ-expanded proteins are modulated by USP19_b through the
chaperone system especially HSP90.
USP19_b deubiquitinates the polyQ-expanded proteins through the
HSP90 functionality
To understand how HSP90 mediates the regulation of the polyQ-expanded substrates by
USP19, we performed co-IP experiment on Atx3100Q and USP19_b. Atx3100Q could be immu-
noprecipitated by USP19_b (Fig 7A), and vice versa (Fig 7B). Moreover, wild-type USP19_b
immunoprecipitated both Atx3100Q and endogenous HSP90 (Fig 7C), whereas the CS domain-
deleted (ΔN393) and mutated (CS12M) variants could not, suggesting that recruitment of
Atx3100Q by USP19_b is directly mediated by HSP90.
Considering that USP19 is a ubiquitin-specific protease, we next investigated the ubiquitina-
tion levels of Atx3100Q and Htt-N552100Q affected by USP19_b. Since isoform I of Atx3 contains
two ubiquitin-interacting motifs (UIMs) that may probably pull down other ubiquitinated pro-
teins, we prepared mutations in the UIM regions of Atx3 (Atx3100Q-UIM
mut, S236A/S256A)
[36, 37]. When co-transfected with wild-type USP19_b, the ubiquitination level of Atx3100Q
was dramatically decreased, while this effect was eliminated upon expression of the C506S
Orchestration of PolyQ-Protein Aggregation by USP19
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mutant (Fig 7D), but no such effect was observed upon co-expression of USP5 (data not
shown). This implies that USP19_b may function as a DUB for regulating the ubiquitination
levels of the polyQ-expanded substrates. Similar effect was also observed in Htt-N552100Q (Fig
7E). On the other hand, two CS-domain mutants of USP19_b, ΔN393 and CS12M, which could
not associate with HSP90 (Fig 7C), had no such reducing effect on the ubiquitination levels (Fig
7F and 7G). Taken together, the HSP90 chaperone is probably involved in the deubiquitination
of the polyQ-expanded substrates by US19_b.
Fig 5. Inhibition of HSP90 down-regulates the protein levels and aggregates of Atx3100Q and Htt-
N552100Q. A andB, Effects of HSP90 inhibitor on the protein levels of Atx3100Q (A) and Htt-N552100Q (B).
FLAG-tagged Atx3100Q or Htt-N552100Q was transfected into HEK 293T cells, and then the cells were treated
with different doses of 17-AAG for 6 hrs (DMSO as a control). About 48 hrs after transfection, the cells were
harvested and lysed for Western blotting. C andD, Effects of HSP90 inhibitor on the SDS-resistant
aggregates of Atx3100Q (C) and Htt-N552100Q (D) by filter trap analysis. Data were quantitated with relative
band intensities and presented as Mean ± SEM (n = 3).
doi:10.1371/journal.pone.0147515.g005
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Fig 6. CS-domain mutation eliminates the promoting effects of USP19_b on Atx3100Q and Htt-
N552100Q. A andB, Effects of CS-domain mutation on the protein levels of Atx3100Q and Htt-N552100Q.
FLAG-tagged Atx3100Q (A) or Htt-N552100Q (B) was co-transfected with HA-USP19_b or its CS12Mmutant
into HEK 293T cells. About 48 hrs after transfection, the total protein levels were analyzed byWestern
blotting with an anti-FLAG antibody. C andD, Effects of CS-domain mutation on the aggregates of Atx3100Q
and Htt-N552100Q. The SDS-resistant aggregates of Atx3100Q (C) and Htt-N552100Q (D) were analyzed by
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filter trap. Data were quantitated with the relative band intensities and presented as Mean ± SEM (n = 3). *,
p < 0.05; **, p < 0.01; ***, p < 0.001; N.S., no significance.
doi:10.1371/journal.pone.0147515.g006
Fig 7. USP19_b regulates the ubiquitination status of Atx3100Q and Htt-N552100Q through the HSP90
chaperone. A andB, Co-IP experiment showing the association of USP19_b with Atx3100Q. HEK 293T cells
were transfected with HA-USP19_b and FLAG-Atx3100Q, and the co-IP experiments were carried out by
using anti-HA antibody (A) or anti-FLAG antibody (B). Control, IP by using protein A/G only. C, Co-IP
experiment showing USP19_b associates with Atx3100Q mediated by endogenous HSP90. The CS-domain
mutants (ΔN393 and CS12M) were as controls. The cell lysates were prepared for Western blotting with anti-
HA antibody for USP19_b and its mutants, and anti-FLAG antibody for Atx3100Q and an antibody against
endogenous HSP90. ΔN393, the CS-domain mutant of USP19_b with deletion of the N-terminal 393
residues. D and E, USP19_b reduces the ubiquitination levels of Atx3100Q-UIM
mut (D) and Htt-N552100Q (E).
HEK 293T cells were transfected with FLAG-tagged Atx3100Q-UIM
mut or Htt-N552100Q and HA-USP19_b or
its C506Smutant. The FLAG-tagged proteins were immunoprecipitated by using an anti-FLAG antibody, and
subjected to Western blotting with the antibodies against ubiquitin and FLAG, respectively. F andG, Effects
of CS-domain mutation (ΔN393 and CS12M) in USP19_b on the ubiquitination levels of Atx3100Q-UIM
mut (F)
and Htt-N552100Q (G).
doi:10.1371/journal.pone.0147515.g007
Orchestration of PolyQ-Protein Aggregation by USP19
PLOSONE | DOI:10.1371/journal.pone.0147515 January 25, 2016 12 / 16
Discussion
USP19 is a DUB probably involved in regulating the ubiquitination status of substrate proteins.
There are mainly two alternative variants of USP19 identified in human, which have distinct
C-termini. The most widely studied isoform USP19_a contains a TMD for anchoring the pro-
tein on ER membrane [15], and enhances stabilities of several key proteins or enzymes [21–
23]. We studied the regulatory function of cytoplasmic USP19 in defining the fate of the cyto-
plasm-resident polyQ-expanded proteins, Atx3 and Htt-N552, in cell models. We have
revealed that USP19_b up-regulates the protein levels of Atx3100Q and Htt-N552100Q and con-
sequently promotes their aggregation. Although we could not exclude the possibility that other
aggregation-prone or disease-related proteins are regulated by USP19_b, our data provide sup-
porting evidence that USP19_b modulates aggregation of the polyQ-expanded proteins
through HSP90. Note that the ER-resident isoform USP19_a also has this regulatory function.
We speculate that only the C-terminal tail of USP19_a is located in the ER lumen, whereas
most of the functional part is towards the cytoplasm that renders it to act on the cytoplasmic
substrates [15, 20]. Both forms of USP19 specifically interact with HSP90 through their N-ter-
minal CS domains and then associate with CHIP via HSP90. Thus, considering the regulatory
role of HSP90 on misfolded proteins [38], it is suggestive that USP19 is involved in quality con-
trol for the cytoplasmic misfolded proteins through the HSP90 chaperone.
The major finding of this work is that cytoplasmic USP19 can promote aggregation of the
polyQ-expanded Atx3 and Htt proteins by up-regulating their protein levels. Although
USP19_b also up-regulates the protein levels of endogenous Atx3, and overexpressed Atx322Q
and Htt-N55218Q, we have not observed the aggregates or inclusions formed by overexpressed
proteins with normal polyQ lengths (Atx322Q, Htt-N55218Q) in the cultured cells, even in the
presence of overexpressed USP19_b (Fig 2). This means that expansion of polyQ tract provides
a potential for Atx3 and Htt-N552 to form insoluble aggregates; and cooperating with HSP90,
USP19 aggravates the aggregation of these polyQ-expanded proteins and enhances their
cytotoxicities.
We have demonstrated that USP19_b specifically interacts with HSP90, where HSP90
recruits CHIP and the misfolded substrate to delicately regulate ubiquitination status of the
substrate. The HSP90 molecule is a hub for protein triage and maturation of a variety of client
proteins [38], which can rescue cells from toxicities of the polyQ-expanded proteins and pre-
vent degeneration [39]. Inhibition of HSP90 can result in the degradation of its substrates
including polyQ-expanded proteins [35, 40]. We have demonstrated that the HSP90 inhibitor
17-AAG can decrease the protein level of Atx3100Q or Htt-N552100Q and consequently alleviate
their aggregation. The degradation of HSP90 substrates induced by 17-AAG treatment is prob-
ably due to inhibition of HSP90 activity and disruption of HSP90-substrate interaction [40].
Furthermore, 17-AAG can activate heat shock response through dissociation of heat-shock
transcription factor (HSF-1) from HSP90 and induction of HSP70 or other HSPs mediated by
HSF-1 [41]. Thus HSP70 is also probably involved in the degradation of HSP90 substrates after
17-AAG treatment. This implicates a tight connection and a delicate balance between the
molecular chaperone and ubiquitin-proteasome systems [6].
USP19 is a multi-domain protein functioning both as a DUB and a co-chaperone protein;
its cytoplasmic isoform can regulate misfolded polyQ-expanded proteins through the HSP90
chaperone. HSP90 recruits the misfolded substrate for refolding or rescue, which may promote
stabilization of the substrate and consequently up-regulate its biological function. With the
help of HSP90, CHIP can ubiquitinate the substrate that fails to be refolded for degradation in
proteasome, which results in reduction of the protein level of the substrate. On the other hand,
the USP domain of USP19 deubiquitinates the substrate and prevents it from degradation,
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which leads to aggregation of the misfolded substrate. Thus, the dual function of USP19 may
play an important role in orchestrating the client proteins. This mechanism of triage decision
through the HSP90 chaperone may have significance in balancing the refolding, degradation
and aggregation of the polyQ-expanded proteins. Breakdown of the homeostasis by physiologi-
cal stress or genetic mutations is potentially the pathological cause of the polyQ diseases [32],
while targeting this homeostatic pathway by small-molecule compounds may provide a prom-
ising therapeutic strategy for these aggravating diseases.
Supporting Information
S1 Fig. The USP19_b isoform is a cytoplasmic ubiquitin-specific protease.
(PDF)
S2 Fig. Domain architectures of isoform I of ataxin-3 (Atx3) and N-terminal huntingtin
(Htt-N552, residues 1–552).
(PDF)
S3 Fig. USP19_b increases the protein levels of Atx3 and Htt-N552.
(PDF)
S4 Fig. Contrasting experiments for the regulatory effects of USP19_b on the substrate pro-
teins.
(PDF)
S5 Fig. Supernatant/pellet fractionation showing that USP19_b up-regulates aggregation
of Atx3100Q in transiently overexpressing cells.
(PDF)
S6 Fig. CS-domain mutation in USP19_b eliminates the promoting effects on the protein
levels of overexpressed Atx322Q and Htt-N55218Q.
(PDF)
Acknowledgments
The authors would like to thank Drs. R. G. Hu, X. W. Zhang and X. C. Gao for technical help
and valuable discussion.
Author Contributions
Conceived and designed the experiments: HYH FGGWTH XMZ. Performed the experiments:
WTH XMZ YHZ. Analyzed the data: WTH XMZ YGG AXS HYH. Wrote the paper: WTH
XMZ HYH.
References
1. Powers ET, Morimoto RI, Dillin A, Kelly JW, BalchWE. Biological and chemical approaches to diseases
of proteostasis deficiency. Annu Rev Biochem. 2009; 78:959–91. PMID: 19298183. doi: 10.1146/
annurev.biochem.052308.114844
2. BalchWE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science.
2008; 319(5865):916–9. PMID: 18276881. doi: 10.1126/science.1141448
3. Kubota H. Quality control against misfolded proteins in the cytosol: a network for cell survival. J Bio-
chem. 2009; 146(5):609–16. PMID: 19737776. doi: 10.1093/jb/mvp139
4. McClellan AJ, Tam S, Kaganovich D, Frydman J. Protein quality control: chaperones culling corrupt
conformations. Nat Cell Biol. 2005; 7(8):736–41. PMID: 16056264.
Orchestration of PolyQ-Protein Aggregation by USP19
PLOSONE | DOI:10.1371/journal.pone.0147515 January 25, 2016 14 / 16
5. Esser C, Alberti S, Hohfeld J. Cooperation of molecular chaperones with the ubiquitin/proteasome sys-
tem. Biochim Biophys Acta. 2004; 1695(1–3):171–88. PMID: 15571814.
6. Gao X, Hu H. Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim
Biophys Sin (Shanghai). 2008; 40(7):612–8. PMID: 18604452.
7. Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature.
2011; 475(7356):324–32. PMID: 21776078. doi: 10.1038/nature10317
8. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Sci-
ence. 2002; 295(5561):1852–8. PMID: 11884745.
9. Gao XC, Zhou CJ, Zhou ZR, Zhang YH, Zheng XM, Song AX, et al. Co-chaperone HSJ1a dually regu-
lates the proteasomal degradation of ataxin-3. PLoS One. 2011; 6(5):e19763. PMID: 21625540. doi:
10.1371/journal.pone.0019763
10. Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and cellular roles of ubiquitin-specific deubiquiti-
nating enzymes. Annu Rev Biochem. 2009; 78:363–97. PMID: 19489724. doi: 10.1146/annurev.
biochem.78.082307.091526
11. Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases.
Nat Rev Mol Cell Biol. 2009; 10(8):550–63. Epub 2009/07/25. nrm2731 [pii] doi: 10.1038/nrm2731
PMID: 19626045.
12. Bauer PO, Nukina N. The pathogenic mechanisms of polyglutamine diseases and current therapeutic
strategies. J Neurochem. 2009; 110(6):1737–65. PMID: 19650870. doi: 10.1111/j.1471-4159.2009.
06302.x
13. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000; 23:217–47.
PMID: 10845064.
14. Combaret L, Adegoke OA, Bedard N, Baracos V, Attaix D, Wing SS. USP19 is a ubiquitin-specific pro-
tease regulated in rat skeletal muscle during catabolic states. Am J Physiol Endocrinol Metab. 2005;
288(4):E693–700. PMID: 15562254.
15. Hassink GC, Zhao B, Sompallae R, Altun M, Gastaldello S, Zinin NV, et al. The ER-resident ubiquitin-
specific protease 19 participates in the UPR and rescues ERAD substrates. EMBORep. 2009; 10
(7):755–61. PMID: 19465887. doi: 10.1038/embor.2009.69
16. Blatch GL, Lassle M. The tetratricopeptide repeat: a structural motif mediating protein-protein interac-
tions. Bioessays. 1999; 21(11):932–9. PMID: 10517866.
17. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, et al. Identification of CHIP, a novel tetratri-
copeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates
chaperone functions. Mol Cell Biol. 1999; 19(6):4535–45. PMID: 10330192.
18. Zhang M, Boter M, Li K, Kadota Y, Panaretou B, Prodromou C, et al. Structural and functional coupling
of Hsp90- and Sgt1-centred multi-protein complexes. Embo J. 2008; 27(20):2789–98. PMID:
18818696. doi: 10.1038/emboj.2008.190
19. Wiles B, Miao M, Coyne E, Larose L, Cybulsky AV, Wing SS. USP19 deubiquitinating enzyme inhibits
muscle cell differentiation by suppressing unfolded-protein response signaling. Mol Biol Cell. 2015; 26
(5):913–23. Epub 2015/01/09. mbc.E14-06-1129 [pii] doi: 10.1091/mbc.E14-06-1129 PMID:
25568336.
20. Lee JG, KimW, Gygi S, Ye Y. Characterization of the deubiquitinating activity of USP19 and its role in
endoplasmic reticulum-associated degradation. J Biol Chem. 2014; 289(6):3510–7. Epub 2013/12/21.
M113.538934 [pii] doi: 10.1074/jbc.M113.538934 PMID: 24356957.
21. Lu Y, Adegoke OA, Nepveu A, Nakayama KI, Bedard N, Cheng D, et al. USP19 deubiquitinating
enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1. Mol Cell Biol.
2009; 29(2):547–58. PMID: 19015242. doi: 10.1128/MCB.00329-08
22. Mei Y, Hahn AA, Hu S, Yang X. The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2.
J Biol Chem. 2011; 286(41):35380–7. PMID: 21849505. doi: 10.1074/jbc.M111.282020
23. Altun M, Zhao B, Velasco K, Liu H, Hassink G, Paschke J, et al. Ubiquitin-specific protease 19 (USP19)
regulates hypoxia-inducible factor 1alpha (HIF-1alpha) during hypoxia. J Biol Chem. 2012; 287
(3):1962–9. PMID: 22128162. doi: 10.1074/jbc.M111.305615
24. Todi SV, Paulson HL. Balancing act: deubiquitinating enzymes in the nervous system. Trends Neu-
rosci. 2011; 34(7):370–82. Epub 2011/06/28. S0166-2236(11)00075-0 [pii] doi: 10.1016/j.tins.2011.05.
004 PMID: 21704388.
25. Jiang YJ, Che MX, Yuan JQ, Xie YY, Yan XZ, Hu HY. Interaction with polyglutamine-expanded hunting-
tin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA). J
Biol Chem. 2011; 286(28):25236–45. Epub 2011/05/14. M110.216333 [pii] doi: 10.1074/jbc.M110.
216333 PMID: 21566141.
Orchestration of PolyQ-Protein Aggregation by USP19
PLOSONE | DOI:10.1371/journal.pone.0147515 January 25, 2016 15 / 16
26. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, et al. Huntingtin-
encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell.
1997; 90(3):549–58. Epub 1997/08/08. S0092-8674(00)80514-0 [pii]. PMID: 9267034.
27. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydroge-
nase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immu-
nol Methods. 1988; 115(1):61–9. PMID: 3192948.
28. Venter JC, AdamsMD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human
genome. Science. 2001; 291(5507):1304–51. PMID: 11181995.
29. Zhang YH, Zhou CJ, Zhou ZR, Song AX, Hu HY. Domain Analysis Reveals That a Deubiquitinating
Enzyme USP13 Performs Non-Activating Catalysis for Lys63-Linked Polyubiquitin. PLoS One. 2011; 6
(12):e29362. Epub 2012/01/05. doi: 10.1371/journal.pone.0029362 PONE-D-11-14452 [pii]. PMID:
22216260.
30. CheMX, Jiang YJ, Xie YY, Jiang LL, Hu HY. Aggregation of the 35-kDa fragment of TDP-43 causes for-
mation of cytoplasmic inclusions and alteration of RNA processing. FASEB J. 2011; 25(7):2344–53.
Epub 2011/04/01. fj.10-174482 [pii] doi: 10.1096/fj.10-174482 PMID: 21450909.
31. Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, Hipp MS, et al. PolyQ proteins interfere with
nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell. 2013; 154
(1):134–45. Epub 2013/06/25. S0092-8674(13)00704-6 [pii] doi: 10.1016/j.cell.2013.06.003 PMID:
23791384.
32. Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum
Mol Genet. 2003; 12 Spec No 2:R173–86. PMID: 14504263.
33. Nagai Y, Popiel HA. Conformational changes and aggregation of expanded polyglutamine proteins as
therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis. Curr Pharm Des.
2008; 14(30):3267–79. PMID: 19075705.
34. Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S, et al. Molecular clearance of
ataxin-3 is regulated by a mammalian E4. Embo J. 2004; 23(3):659–69. PMID: 14749733.
35. Waza M, Adachi H, Katsuno M, MinamiyamaM, Sang C, Tanaka F, et al. 17-AAG, an Hsp90 inhibitor,
ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med. 2005; 11(10):1088–95.
PMID: 16155577.
36. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. Ubiquitin-mediated sequestration of
normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A. 2003; 100(15):8892–
7. PMID: 12857950.
37. Song AX, Zhou CJ, Peng Y, Gao XC, Zhou ZR, Fu QS, et al. Structural transformation of the tandem
ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS
One. 2010; 5(10):e13202. PMID: 20949063. doi: 10.1371/journal.pone.0013202
38. Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic
insights. Nat Rev Mol Cell Biol. 2010; 11(7):515–28. PMID: 20531426. doi: 10.1038/nrm2918
39. Williams AJ, Knutson TM, Colomer Gould VF, Paulson HL. In vivo suppression of polyglutamine neuro-
toxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogen-
esis. Neurobiol Dis. 2009; 33(3):342–53. PMID: 19084066. doi: 10.1016/j.nbd.2008.10.016
40. Baldo B, Weiss A, Parker CN, Bibel M, Paganetti P, Kaupmann K. A screen for enhancers of clearance
identifies huntingtin as a heat shock protein 90 (Hsp90) client protein. J Biol Chem. 2012; 287(2):1406–
14. Epub 2011/11/30. M111.294801 [pii] doi: 10.1074/jbc.M111.294801 PMID: 22123826.
41. Herbst M, Wanker EE. Small molecule inducers of heat-shock response reduce polyQ-mediated hun-
tingtin aggregation. A possible therapeutic strategy. Neurodegener Dis. 2007; 4(2–3):254–60. Epub
2007/06/29. 000101849 [pii] doi: 10.1159/000101849 PMID: 17596719.
Orchestration of PolyQ-Protein Aggregation by USP19
PLOSONE | DOI:10.1371/journal.pone.0147515 January 25, 2016 16 / 16
